291 related articles for article (PubMed ID: 17531561)
1. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma.
Al-Toma A; Verbeek WH; Visser OJ; Kuijpers KC; Oudejans JJ; Kluin-Nelemans HC; Mulder CJ; Huijgens PC
Dig Liver Dis; 2007 Jul; 39(7):634-41. PubMed ID: 17531561
[TBL] [Abstract][Full Text] [Related]
2. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W
Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
Bishton MJ; Haynes AP
Br J Haematol; 2007 Jan; 136(1):111-3. PubMed ID: 17116129
[TBL] [Abstract][Full Text] [Related]
4. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
5. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases.
Tsuchiyama J; Imajo K; Yoshino T; Nanba N; Toyota A; Yoshida C; Fujii K; Kondo E; Okazuka K; Hashimoto S; Toba K; Fuse I; Aizawa Y; Harada M; Tsubota T
Ann Hematol; 2002 Oct; 81(10):588-92. PubMed ID: 12424541
[TBL] [Abstract][Full Text] [Related]
7. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
Ozdogu H; Boga C; Kizilkilic E; Kozanoglu I; Karakus S; Sahin FI; Unalan D; Haberal M
Transplant Proc; 2007 May; 39(4):1257-60. PubMed ID: 17524948
[TBL] [Abstract][Full Text] [Related]
8. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
[TBL] [Abstract][Full Text] [Related]
10. Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
Smith SD; Bolwell BJ; Rybicki LA; Brown S; Dean R; Kalaycio M; Sobecks R; Andresen S; Hsi ED; Pohlman B; Sweetenham JW
Bone Marrow Transplant; 2007 Aug; 40(3):239-43. PubMed ID: 17530000
[TBL] [Abstract][Full Text] [Related]
11. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
Tang SQ; Huang DS; Wang JW; Feng C; Yang G
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
[TBL] [Abstract][Full Text] [Related]
12. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
13. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
Torjman L; Ladeb S; Lakhal A; Ben Othman T; Abdelkefi A; Ben Abdeladhim A
Tunis Med; 2007 Jan; 85(1):35-8. PubMed ID: 17424707
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
Kroschinsky F; Hölig K; Platzbecker U; Poppe-Thiede K; Ordemann R; Blechschmidt M; Oelschlaegel U; Schaich M; Hänel M; Bornhäuser M; Ehninger G
Transfusion; 2006 Aug; 46(8):1417-23. PubMed ID: 16934080
[TBL] [Abstract][Full Text] [Related]
15. High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma.
Ingen-Housz-Oro S; Bachelez H; Verola O; Lebbé C; Marolleau JP; Hennequin C; Dubertret L; Morel P; Gisselbrecht C; Brice P
Bone Marrow Transplant; 2004 Mar; 33(6):629-34. PubMed ID: 14755323
[TBL] [Abstract][Full Text] [Related]
16. Long-term remission of blastic natural killer-cell lymphoma after autologous peripheral blood stem-cell transplantation.
Yamaguchi M; Maekawa M; Nakamura Y; Ueda M
Am J Hematol; 2005 Oct; 80(2):124-7. PubMed ID: 16184583
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation].
Zhao Y; Zhou DB; Leng XM; Wang SJ; Li TS; Duan Y; Shen T; Zhao YQ; Zhang JP; Bai LJ; Cui W; Zhang FQ; Zeng XF; Zhang FC; Dong Y; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2077-81. PubMed ID: 15730620
[TBL] [Abstract][Full Text] [Related]
19. Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma.
Kim JG; Sohn SK; Chae YS; Yang DH; Lee JJ; Kim HJ; Shin HJ; Jung JS; Kim WS; Kim DH; Suh C; Kim SJ; Eom HS; Bae SH
Bone Marrow Transplant; 2007 Nov; 40(10):919-24. PubMed ID: 17846602
[TBL] [Abstract][Full Text] [Related]
20. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
